Carregant...
Pegfilgrastim Biosimilars: Where Are We Now?
In 1991, the U.S. Food & Drug Administration (FDA) approved rmetHuGCSF for human use. This recombinant methionyl human granulocyte colony-stimulating factor, or filgrastim, saw use in over 1 million patients in its first 5 years on the market. In 2002, the FDA approved a version of filgrastim wi...
Guardat en:
| Publicat a: | J Adv Pract Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Harborside Press LLC
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8299796/ https://ncbi.nlm.nih.gov/pubmed/34430064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2021.12.5.9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|